• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过被动吸收唾液评估儿童口服缓释型茶碱的生物利用度。

Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children.

作者信息

Vaughan L M, Milavetz G, Weinberger M M, Smith G D, Merrick J G

机构信息

Pediatric Allergy/Pulmonary Division, College of Pharmacy, University of Iowa, Iowa City 52242.

出版信息

Drug Intell Clin Pharm. 1988 Sep;22(9):684-7. doi: 10.1177/106002808802200906.

DOI:10.1177/106002808802200906
PMID:3215109
Abstract

Assessment in young children of the bioavailability of slow-release theophylline formulations is hampered by the requirement for frequent blood sampling. Calculations of bioavailability from serial serum and passively absorbed saliva samples were therefore compared in six 9- to 12-year-old asthmatic children receiving multiple doses of Theo-Dur Sprinkle every 12 hours, using Theo-Dur tablets, a previously characterized formulation, as a reference. Results indicated 85 +/- 5 percent and 82 +/- 8 percent (mean +/- SEM) relative bioavailability based on serum and salivary measurements, respectively. Correlation coefficient for serum and passively absorbed saliva bioavailabilities was 0.90. Passively absorbed saliva provides an acceptably accurate, noninvasive method for theophylline bioavailability assessment and may be a useful alternative for bioavailability studies in young children.

摘要

频繁采血的要求妨碍了对幼儿缓释茶碱制剂生物利用度的评估。因此,在6名9至12岁的哮喘儿童中进行了比较,这些儿童每12小时接受多剂量的Theo-Dur Sprinkle治疗,以先前已明确特性的Theo-Dur片剂作为对照,计算连续血清样本和被动吸收唾液样本的生物利用度。结果表明,基于血清测量和唾液测量的相对生物利用度分别为85±5%和82±8%(平均值±标准误)。血清生物利用度和被动吸收唾液生物利用度的相关系数为0.90。被动吸收唾液为茶碱生物利用度评估提供了一种可接受的准确、非侵入性方法,可能是幼儿生物利用度研究的一种有用替代方法。

相似文献

1
Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children.通过被动吸收唾液评估儿童口服缓释型茶碱的生物利用度。
Drug Intell Clin Pharm. 1988 Sep;22(9):684-7. doi: 10.1177/106002808802200906.
2
Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma.
Ther Drug Monit. 1988;10(4):395-400. doi: 10.1097/00007691-198804000-00005.
3
Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.每日一次和每日两次茶碱给药系统的药代动力学比较。
Clin Ther. 1994 Jul-Aug;16(4):686-92.
4
Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
Asian Pac J Allergy Immunol. 2001 Jun;19(2):69-78.
5
Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
Int J Clin Pharmacol Ther Toxicol. 1986 Apr;24(4):196-201.
6
Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.进餐和剂型改变对茶碱从24小时缓释给药系统中生物利用度的影响。
Clin Ther. 1994 Sep-Oct;16(5):804-14.
7
Theophylline pharmacokinetics in children, comparing sustained release spheres (Theo-Dur sprinkle) with elixir.儿童体内茶碱的药代动力学:比较缓释微球(Theo-Dur分散片)与酏剂。
Eur J Pediatr. 1988 Dec;148(3):278-80. doi: 10.1007/BF00441421.
8
Bioequivalence of a generic slow-release theophylline tablet in children.儿童用仿制缓释茶碱片的生物等效性
J Pediatr. 1994 Dec;125(6 Pt 1):987-91. doi: 10.1016/s0022-3476(05)82021-9.
9
Effects of time of dose in relation to food on the bioavailability of Theo-Dur Sprinkle at steady state in asthmatic children.哮喘儿童中,剂量时间与食物的关系对稳态时茶喘平胶囊生物利用度的影响。
Clin Pharmacol Ther. 1989 Mar;45(3):305-11. doi: 10.1038/clpt.1989.33.
10
Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
J Pharm Sci. 1987 Oct;76(10):784-7. doi: 10.1002/jps.2600761006.

引用本文的文献

1
Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.新型药物递送系统。其对临床药代动力学研究影响的概述。
Clin Pharmacokinet. 1991 Jan;20(1):1-14. doi: 10.2165/00003088-199120010-00001.